CXSS2400053 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-05-28 | | Shandong BoAn Biotechnology Co Ltd | | | view |
CXSS2400052 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-05-28 | | Shandong BoAn Biotechnology Co Ltd | | | view |
CXSS2400054 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-05-28 | | Shandong BoAn Biotechnology Co Ltd | | | view |
CXSS2400051 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-05-28 | | Shandong BoAn Biotechnology Co Ltd | | | view |
JYSZ2300032 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | License Renew | 2023-08-01 | | | | | view |
JYSZ2300033 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | License Renew | 2023-08-01 | | | | | view |
JXSS2300006 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-11 | | | | | view |
JXSS2300005 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-11 | | | | | view |
CXSL2101196 | LY05008注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2021-07-15 | | Shandong BoAn Biotechnology Co Ltd | | | view |
CXSL2101197 | LY05008注射液 | dulaglutide | Injection | Biological Products(3.3) | New Drug Application | 2021-07-15 | | Shandong BoAn Biotechnology Co Ltd | | | view |
JYSB2000419 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-08-24 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-02 | view |
JYSB2000418 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-08-24 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-02 | view |
JYSB2000250 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-06-19 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-06-22 | view |
JYSB2000251 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-06-19 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-06-22 | view |
JXSL2000046 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Import Drug Application | 2020-05-11 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2020-04-30 | view |
JXSL2000045 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Import Drug Application | 2020-05-09 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2020-04-30 | view |
JYSB2000074 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-03-14 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-05-26 | view |
JYSB2000073 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-03-14 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-05-26 | view |
JYSB2000050 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-02-19 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-09-27 | view |
JYSB2000049 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-02-19 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-09-27 | view |